Press/Media
- 23 results
Search results
-
-
Reports from Icahn School of Medicine at Mount Sinai Describe Recent Advances in Multiple Myeloma (High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments)
Kim-Schulze, S., Rahman, A., Parekh, S., Cho, H. & Gnjatic, S.
11/09/23
1 item of Media coverage
Press/Media
-
Study Data from Icahn School of Medicine at Mount Sinai Update Knowledge of Multiple Myeloma (Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma)
Cho, H., Gulati, N. & Niedt, G.
9/08/23
1 item of Media coverage
Press/Media
-
New Findings from Icahn School of Medicine at Mount Sinai Describe Advances in Multiple Myeloma (Trial Designs and Endpoints for Immune Therapies In Multiple Myeloma)
Richter, J., Parekh, S., Jagannath, S., Moshier, E., Lancman, G., Cho, H., Rodriguez, C. & Chari, A.
8/12/22
1 item of Media coverage
Press/Media
-
MMRF Data Fuels Greater Understanding of Multiple Myeloma Drug Resistance, Mutational Landscape
24/08/22
1 item of Media coverage
Press/Media
-
Molecular Drivers of Multiple Myeloma and Treatment Resistance Identified
28/07/22
1 item of Media coverage
Press/Media
-
Researchers find link between genetic mutations and cancer treatment resistance
27/07/22
1 item of Media coverage
Press/Media
-
Researchers find link between genetic mutations and cancer treatment resistance
26/07/22
6 items of Media coverage
Press/Media
-
-
New Orleans partnership aims to cure cancer that kills twice as many Black people
18/03/22
1 item of Media coverage
Press/Media
-
Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating Mul
14/12/21
44 items of Media coverage
Press/Media
-
Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting
14/12/21
1 item of Media coverage
Press/Media
-
Data from MMRF Landmark CoMMpass Study Validated as Unparalleled in Cancer Research at 63rd American Society of Hematology (ASH) Annual Meeting'
10/12/21
1 item of Media coverage
Press/Media
-
Data from MMRF Landmark CoMMpass Study Validated as Unparalleled in Cancer Research at 63rd American Society of Hematology (ASH) Annual Meeting
10/12/21
31 items of Media coverage
Press/Media
-
Scientists identify new types of a blood cancer and potential targeted treatments
Melnekoff, D., Richter, J., Parekh, S., Leshchenko, V. V., Jagannath, S., Laganà, A., Onel, K. & Cho, H.
17/11/21
1 item of Media coverage
Press/Media
-
The MMRF Drives Unparalleled Advances for Multiple Myeloma Patients
4/12/20
1 item of Media coverage
Press/Media
-
The MMRF Drives Unparalleled Advances for Multiple Myeloma Patients
3/12/20 → 4/12/20
28 items of Media coverage
Press/Media
-
Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma
22/10/20
1 item of Media coverage
Press/Media
-
Patients with Multiple Myeloma Who Join MMRF's CureCloud May Improve Their Treatment Options While Contributing to Research
14/07/20
1 item of Media coverage
Press/Media
-
Multiple Myeloma Research Foundation (MMRF) Launches CureCloud To Democratize Healthcare For Cancer Patients
14/07/20
14 items of Media coverage
Press/Media
-
Multiple Myeloma Research Foundation (MMRF) Launches CureCloud to Democratize Healthcare for Cancer Patients
14/07/20
1 item of Media coverage
Press/Media